Hielke J. Meulenbeld

Efficacy of Cabazitaxel in Castration-resistant Prostate Cancer Is Independent of the Presence of AR-V7 in Circulating Tumor Cells

Wendy Onstenk, Anieta M. Sieuwerts, Jaco Kraan et al. · European Urology · 2015 · 237 citations

Urology, Oncology, Genitourinary Cancer +8

Survival after adjuvant 5‐FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer

Wouter H. de Vos tot Nederveen Cappel, Hielke J. Meulenbeld, Jan H. Kleibeuker et al. · International Journal of Cancer · 2004 · 117 citations

Tumor Biology, Mmr Gene, Gastrointestinal Oncology +12

Randomized phase <scp>II</scp> study of danusertib in patients with metastatic castration‐resistant prostate cancer after docetaxel failure

Hielke J. Meulenbeld, Jean Pierre Bleuse, Elio M. Vinci et al. · British Journal of Urology · 2012 · 76 citations

Significant improvement in survival of patients presenting with metastatic colon cancer in the south of The Netherlands from 1990 to 2004

Hielke J. Meulenbeld, Liza N. van Steenbergen, M.L.G. Janssen‐Heijnen et al. · Annals of Oncology · 2008 · 50 citations · Full text

Surgical Oncology, Metastatic Colon Cancer, Gastrointestinal Oncology +11

Randomised phase II/III study of docetaxel with or without risedronate in patients with metastatic Castration Resistant Prostate Cancer (CRPC), the Netherlands Prostate Study (NePro)

Hielke J. Meulenbeld, Erik van Werkhoven, J.L. Coenen et al. · European Journal of Cancer · 2012 · 35 citations

Surgical Oncology, Urology, Genitourinary Cancer +6